Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. 3 Insider Initial Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 8-K Event Executive or director change
  15. SC 13G Stake Amended Statement of Ownership
  16. SC 13G Stake Amended Statement of Ownership
  17. 5 Insider Annual Insider Trading Report
  18. SC 13G Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. 4/A Insider Changes in Ownership

Page 34 of 38 · 752 filings